Jiangsu Lanfeng Bio-chemical Co Ltd (002513) - Net Assets
Based on the latest financial reports, Jiangsu Lanfeng Bio-chemical Co Ltd (002513) has net assets worth CN¥347.80 Million CNY (≈ $50.89 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥4.06 Billion ≈ $594.16 Million USD) and total liabilities (CN¥3.71 Billion ≈ $543.27 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 002513 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥347.80 Million |
| % of Total Assets | 8.57% |
| Annual Growth Rate | 8.75% |
| 5-Year Change | -46.75% |
| 10-Year Change | -85.86% |
| Growth Volatility | 89.14 |
Jiangsu Lanfeng Bio-chemical Co Ltd - Net Assets Trend (2007–2025)
This chart illustrates how Jiangsu Lanfeng Bio-chemical Co Ltd's net assets have evolved over time, based on quarterly financial data. See Jiangsu Lanfeng Bio-chemical Co Ltd (002513) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Jiangsu Lanfeng Bio-chemical Co Ltd (2007–2025)
The table below shows the annual net assets of Jiangsu Lanfeng Bio-chemical Co Ltd from 2007 to 2025. For live valuation and market cap data, see 002513 stock market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥355.01 Million ≈ $51.95 Million |
+13.57% |
| 2024-12-31 | CN¥312.58 Million ≈ $45.74 Million |
+24.70% |
| 2023-12-31 | CN¥250.66 Million ≈ $36.68 Million |
-29.90% |
| 2022-12-31 | CN¥357.59 Million ≈ $52.33 Million |
-46.36% |
| 2021-12-31 | CN¥666.64 Million ≈ $97.55 Million |
-42.53% |
| 2020-12-31 | CN¥1.16 Billion ≈ $169.73 Million |
+2.16% |
| 2019-12-31 | CN¥1.14 Billion ≈ $166.14 Million |
-31.49% |
| 2018-12-31 | CN¥1.66 Billion ≈ $242.49 Million |
-34.58% |
| 2017-12-31 | CN¥2.53 Billion ≈ $370.68 Million |
+0.89% |
| 2016-12-31 | CN¥2.51 Billion ≈ $367.42 Million |
+4.32% |
| 2015-12-31 | CN¥2.41 Billion ≈ $352.21 Million |
+109.48% |
| 2014-12-31 | CN¥1.15 Billion ≈ $168.14 Million |
-3.15% |
| 2013-12-31 | CN¥1.19 Billion ≈ $173.61 Million |
+0.41% |
| 2012-12-31 | CN¥1.18 Billion ≈ $172.91 Million |
+3.68% |
| 2011-12-31 | CN¥1.14 Billion ≈ $166.77 Million |
+5.75% |
| 2010-12-31 | CN¥1.08 Billion ≈ $157.70 Million |
+343.53% |
| 2009-12-31 | CN¥242.98 Million ≈ $35.56 Million |
+34.39% |
| 2008-12-31 | CN¥180.80 Million ≈ $26.46 Million |
+130.46% |
| 2007-12-31 | CN¥78.45 Million ≈ $11.48 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Jiangsu Lanfeng Bio-chemical Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 17423.6% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | CN¥2.69 Billion | 6149.60% |
| Total Equity | CN¥43.69 Million | 100.00% |
Jiangsu Lanfeng Bio-chemical Co Ltd Competitors by Market Cap
The table below lists competitors of Jiangsu Lanfeng Bio-chemical Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PrimeEnergy Corporation
NASDAQ:PNRG
|
$283.62 Million |
|
FVCBankcorp Inc
NASDAQ:FVCB
|
$283.63 Million |
|
AIM Industrial Growth Freehold and Leasehold Real Estate Investment Trust
BK:AIMIRT
|
$283.71 Million |
|
Global Atomic Corp
TO:GLO
|
$283.73 Million |
|
Bali Towerindo Sentra Tbk
JK:BALI
|
$283.58 Million |
|
Garanti Faktoring AS
IS:GARFA
|
$283.47 Million |
|
Wanxiang Doneed Co Ltd
SHG:600371
|
$283.42 Million |
|
Qudian Inc
F:1QU
|
$283.31 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Jiangsu Lanfeng Bio-chemical Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 32,536,860 to 43,689,201, a change of 11,152,341 (34.3%).
- Net loss of 190,525,338 reduced equity.
- Dividend payments of 32,652,429 reduced retained earnings.
- Other comprehensive income decreased equity by 3,258,980.
- Other factors increased equity by 237,589,088.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥-190.53 Million | -436.09% |
| Dividends Paid | CN¥32.65 Million | -74.74% |
| Other Comprehensive Income | CN¥-3.26 Million | -7.46% |
| Other Changes | CN¥237.59 Million | +543.82% |
| Total Change | CN¥- | 34.28% |
Book Value vs Market Value Analysis
This analysis compares Jiangsu Lanfeng Bio-chemical Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 44.36x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has increased from 10.18x to 44.36x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2007-12-31 | CN¥0.51 | CN¥5.16 | x |
| 2008-12-31 | CN¥1.14 | CN¥5.16 | x |
| 2009-12-31 | CN¥1.54 | CN¥5.16 | x |
| 2010-12-31 | CN¥6.58 | CN¥5.16 | x |
| 2011-12-31 | CN¥5.33 | CN¥5.16 | x |
| 2012-12-31 | CN¥5.54 | CN¥5.16 | x |
| 2013-12-31 | CN¥5.62 | CN¥5.16 | x |
| 2014-12-31 | CN¥5.52 | CN¥5.16 | x |
| 2015-12-31 | CN¥11.20 | CN¥5.16 | x |
| 2016-12-31 | CN¥7.49 | CN¥5.16 | x |
| 2017-12-31 | CN¥7.15 | CN¥5.16 | x |
| 2018-12-31 | CN¥4.87 | CN¥5.16 | x |
| 2019-12-31 | CN¥3.34 | CN¥5.16 | x |
| 2020-12-31 | CN¥3.13 | CN¥5.16 | x |
| 2021-12-31 | CN¥1.95 | CN¥5.16 | x |
| 2022-12-31 | CN¥0.96 | CN¥5.16 | x |
| 2023-12-31 | CN¥0.07 | CN¥5.16 | x |
| 2024-12-31 | CN¥0.09 | CN¥5.16 | x |
| 2025-12-31 | CN¥0.12 | CN¥5.16 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Jiangsu Lanfeng Bio-chemical Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -436.09%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -8.13%
- • Asset Turnover: 0.52x
- • Equity Multiplier: 102.47x
- Recent ROE (-436.09%) is below the historical average (-138.73%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2007 | 38.37% | 5.47% | 1.44x | 4.86x | CN¥22.25 Million |
| 2008 | 54.11% | 10.77% | 1.97x | 2.55x | CN¥79.75 Million |
| 2009 | 40.70% | 15.76% | 0.96x | 2.69x | CN¥74.61 Million |
| 2010 | 7.13% | 8.40% | 0.55x | 1.54x | CN¥-30.95 Million |
| 2011 | 7.32% | 7.30% | 0.65x | 1.54x | CN¥-30.50 Million |
| 2012 | 5.01% | 4.67% | 0.54x | 1.97x | CN¥-58.93 Million |
| 2013 | 1.78% | 1.54% | 0.53x | 2.18x | CN¥-97.52 Million |
| 2014 | -3.26% | -2.99% | 0.48x | 2.27x | CN¥-152.37 Million |
| 2015 | -2.86% | -6.81% | 0.25x | 1.68x | CN¥-309.47 Million |
| 2016 | 4.27% | 7.36% | 0.36x | 1.61x | CN¥-143.81 Million |
| 2017 | 1.40% | 1.92% | 0.46x | 1.59x | CN¥-217.87 Million |
| 2018 | -52.80% | -59.06% | 0.42x | 2.13x | CN¥-1.04 Billion |
| 2019 | -45.50% | -34.34% | 0.56x | 2.38x | CN¥-630.09 Million |
| 2020 | 1.28% | 1.10% | 0.58x | 1.99x | CN¥-101.17 Million |
| 2021 | -73.68% | -34.02% | 0.84x | 2.59x | CN¥-557.86 Million |
| 2022 | -89.68% | -22.19% | 0.98x | 4.13x | CN¥-356.45 Million |
| 2023 | -1317.38% | -19.08% | 0.51x | 134.79x | CN¥-334.78 Million |
| 2024 | -776.05% | -14.08% | 0.52x | 105.08x | CN¥-255.75 Million |
| 2025 | -436.09% | -8.13% | 0.52x | 102.47x | CN¥-194.89 Million |
Industry Comparison
This section compares Jiangsu Lanfeng Bio-chemical Co Ltd's net assets metrics with peer companies in the Agricultural Inputs industry.
Industry Context
- Industry: Agricultural Inputs
- Average net assets among peers: $3,810,968,802
- Average return on equity (ROE) among peers: 7.30%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Jiangsu Lanfeng Bio-chemical Co Ltd (002513) | CN¥347.80 Million | 38.37% | 10.67x | $283.60 Million |
| Hubei Yihua Chemical Industry Co Ltd (000422) | $492.29 Million | 7.61% | 0.82x | $2.09 Billion |
| Nanjing Red Sun Co Ltd (000525) | $3.98 Billion | 4.57% | 1.08x | $831.95 Million |
| ADAMA Ltd (000553) | $21.92 Billion | -7.32% | 1.53x | $1.84 Billion |
| Grand Industrial Holding Co Ltd (000626) | $3.10 Billion | 7.17% | 1.46x | $517.47 Million |
| Sichuan Meifeng Chemical Industry Co Ltd (000731) | $3.04 Billion | 5.61% | 0.59x | $440.10 Million |
| Qinghai Salt Lake Industry Co.Ltd (000792) | $634.84 Million | 10.65% | 0.39x | $23.04 Billion |
| Asia Potash International Investment Guangzhou Co Ltd (000893) | $3.93 Billion | 1.06% | 0.07x | $5.53 Billion |
| Hubei Xinyangfeng Fertilizer Co Ltd (000902) | $452.01 Million | -10.57% | 1.67x | $2.23 Billion |
| Sichuan Lutianhua Co Ltd (000912) | $218.75 Million | 71.83% | 0.84x | $782.42 Million |
| Guangxi Hechi Chemical Co Ltd (000953) | $341.44 Million | -17.59% | 1.88x | $297.88 Million |
About Jiangsu Lanfeng Bio-chemical Co Ltd
Jiangsu Lanfeng Bio-chemical Co.,Ltd researches, develops, produces, and sells pesticides, fungicides, insecticides, herbicides, and fine chemical intermediates in China and internationally. It offers carbendazim, thiophanate-methyl, cycloazinone, carbosulfan butyl, sulfuric acid, and surfactant. Jiangsu Lanfeng Bio-chemical Co.,Ltd was founded in 1976 and is based in Xinyi, China.